Anders Castor
31 – 40 of 57
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
The genomic landscape of high hyperdiploid childhood acute lymphoblastic leukemia.
(
- Contribution to journal › Article
-
Mark
Cooperative genetic changes in pediatric B-cell precursor acute lymphoblastic leukemia with deletions or mutations of IKZF1.
(
- Contribution to journal › Article
-
Mark
Genetic and epigenetic characterization of hypodiploid acute lymphoblastic leukemia.
(
- Contribution to journal › Article
- 2014
-
Mark
Deletions of IKZF1 and SPRED1 are associated with poor prognosis in a population-based series of pediatric B-cell precursor acute lymphoblastic leukemia diagnosed between 1992 and 2011.
(
- Contribution to journal › Article
-
Mark
Comparison of MRD monitoring by IG/TR rearrangement and BCR/ABL1 transcript in PH+ pediatric acute lymphoblastic leukemia patients treated with imatinib in the EsPhALL study
(
- Contribution to journal › Published meeting abstract
-
Mark
A nordic platform for clinical ethics in pediatric oncology
2014) 46 Congress of The International Society of Paediatric Oncology In Pediatric Blood & Cancer 61(Suppl. S2). p.363-363(
- Contribution to journal › Published meeting abstract
-
Mark
Comprehensive genetic characterization of pediatric T-cell acute lymphoblastic leukemia
(
- Contribution to journal › Published meeting abstract
- 2013
-
Mark
Quiescent leukaemic cells account for minimal residual disease in childhood lymphoblastic leukaemia
(
- Contribution to journal › Letter
- 2012
-
Mark
Imatinib after induction for treatment of children and adolescents with Philadelphia-chromosome-positive acute lymphoblastic leukaemia (EsPhALL): a randomised, open-label, intergroup study
(
- Contribution to journal › Article
-
Mark
Etikrådet vid Barn- och ungdomssjukhuset i Lund
2012) p.9-20(
- Chapter in Book/Report/Conference proceeding › Book chapter